Breakthrough in Ophthalmology: FDA Approves Samsung Bioepis’ Biosimilar Ophthalmic Drug
Macular degeneration is a severe eye condition that affects millions worldwide, primarily the elderly. This disease deteriorates the central part of the retina, called the macula, leading to vision loss. Eylea (aflibercept) is a leading treatment for macular degeneration, designed to prevent abnormal blood vessel growth in the eye. Developed by Regeneron and Bayer, Eylea’s … 더 읽기